13th Annual Immuno-Oncology Summit

The 13th Annual 2025 Immuno-Oncology Summit showcases successes in preclinical and clinical studies grounded in a deep understanding of biology. Coverage spans solid tumor innovations, including bi/multispecific antibodies, antibody-drug conjugates (ADCs), allogenic and in vivo CAR-Ts , TILs, TCRs, Tregs, multiple cell therapies working together, the tumor microenvironment, innate immunity , gamma delta T cells, NK cells , organoid modeling, data science, and machine learning . The program also